Everest Capital Unveils New Shanghai Digs

May 11 2007 | 11:28am ET

Everest Capital today opened a Shanghai research office to increase the Chinese presence of its Singapore-based pan-Asian research team. Director Xu Yun will head the new office, reporting to Shi Ming Lei, managing director of China Research, and Matthieu Vermersch, senior managing director for Asia, both based in Singapore.

Prior to joining Everest Capital, Xu served as a portfolio manager at China Securities Co. in Shanghai and previously worked as an auditor for Ernst & Young in China.

Marko Dimitrijević, Everest Capital founder and chief investment officer, said, “China is the most important story we may see in our lifetime. The challenge is to understand the macroeconomic scenario and find the companies best suited to gain from China’s broader growth.”

Everest Capital, with more than $2 billion AUM, is currently investing about half of its assets in Asia, where the firm manages three dedicated strategies: Everest Capital Asia, Everest Capital China Opportunity and Everest Capital Japan Opportunity. The strategies invest primarily in equities and opportunistically in debt, currencies and commodities, in long and short positions. The Asia and China strategies allocate between developed and emerging markets.


In Depth

Steinbrugge: Top 10 Hedge Fund Industry Trends for 2017

Jan 3 2017 | 9:03pm ET

Each year, Agecroft Partners' Don Steinbrugge predicts the top hedge fund industry...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

DarcMatter: The Top Trends in Alternative Investments for 2017

Jan 13 2017 | 8:22pm ET

The $7 trillion alternative investments industry is poised for continued growth...

 

From the current issue of

The U.S. Commodity Futures Trading Commission (CFTC) ordered The Goldman Sachs Group Inc., and Goldman, Sachs & Co. to pay a $120 million penalty for attempted manipulation and false reporting of ISDAFIX Benchmark Rates, a global benchmark for interest rate products.